I-Shou University
15 imported, source-linked research records. Published in the last two years.
15 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to I-Shou University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–15 of 15 matching records. Counts update as records arrive.
Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study
August 1, 2026 · 0 citations · Open access
Open original record →Reassessing the risk-modifying effects of novel antidiabetic agents on asthma–COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials
June 19, 2026 · 0 citations · Open access
Open original record →Differential Acute Kidney Injury Profiles of GLP-1RAs and SGLT2is: A Network Meta-Analysis
May 6, 2026 · 0 citations · Open access
Open original record →Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials
March 13, 2026 · 0 citations · Open access
Open original record →The effect of GLP-1 receptor agonist and SGLT2 inhibitor on infection risk: network meta-analysis
January 27, 2026 · 4 citations · Open access
Open original record →Real-world effectiveness of SGLT2 inhibitors in patients with HF and ESKD: a multicenter cohort study
January 16, 2026 · 2 citations · Open access
Open original record →Agent- and Dose-Specific Intestinal Obstruction Safety of GLP-1 Receptor Agonists and SGLT2 Inhibitors: A Network Meta-Analysis of Randomized Trials
January 7, 2026 · 4 citations · Open access
Open original record →The relationship between SGLT2 inhibitors and hearing loss: a nationwide population-based retrospective cohort study
December 29, 2025 · 0 citations · Open access
Open original record →The concentration-dependent protective effects by new generation hypoglycemic agents on delirium, depression, dementia and coma: evidence from a network meta-analysis
December 8, 2025 · 4 citations · Open access
Open original record →The gynecologic tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 91 randomized controlled trials
November 27, 2025 · 6 citations · Open access
Open original record →Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis
November 19, 2025 · 8 citations · Open access
Open original record →Association between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes: a propensity-matched cohort study
October 27, 2025 · 8 citations · Open access
Open original record →The Preventive Effects of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Cancer Metastasis: A Network Meta-Analysis of 67 Randomized Controlled Trials
August 23, 2025 · 8 citations · Open access
Open original record →Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
May 16, 2025 · 10 citations · Open access
Open original record →The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
April 6, 2025 · 26 citations · Open access
Open original record →